Altered expression of transforming growth factor-beta ligands and receptors in primary and recurrent ovarian carcinoma.
about
Modulation of NFkappaB activity and E-cadherin by the type III transforming growth factor beta receptor regulates cell growth and motilityThe role of the tumor stroma in ovarian cancer.Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium.Ovarian cancer: epidemiology, biology, and prognostic factors.TGF-beta blockade controls ascites by preventing abnormalization of lymphatic vessels in orthotopic human ovarian carcinoma models.LY2109761 enhances cisplatin antitumor activity in ovarian cancer cells.TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells.Determination of TGFbeta1 protein level in human primary breast cancers and its relationship with survival.Expression and correlation of Lewis y antigen and TGF-β1 in ovarian epithelial carcinoma.Sphingosine kinase 1 is required for TGF-β mediated fibroblastto- myofibroblast differentiation in ovarian cancer.Defining the role of integrin alphavbeta6 in cancer.TGF-β isoforms induce EMT independent migration of ovarian cancer cells.Interleukin-7 and suppression of local peritoneal immunity in ovarian carcinoma.Reduced expression of transforming growth factor-beta receptor type III in high stage neuroblastomas.Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women.YY1 Over-expression in human brain gliomas and meningiomas correlates with TGF-beta1, IGF-1 and FGF-2 mRNA levels.Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness.[Defective expression of TGFBR3 gene and its molecular mechanisms in non-small cell lung cancer cell lines].
P2860
Q28594979-FD169E2B-B306-47DD-8EE0-F9FAF136868CQ33633856-4B05A30C-CDFA-44B2-9A5C-2994D303082CQ33921008-9483ACEB-0BE3-4CEB-8A17-16491B5F4828Q33959805-6E505161-4CB7-48C5-A632-2F2E9AC419EFQ34694524-8FC06D70-5FF2-4F7B-8551-684DA6B3CEEEQ35854002-0AC8F104-7A20-4373-8C8D-9C139AE61838Q36213724-33BA334C-EDB5-4F25-8634-75285F55D695Q36613581-5B840CAE-D30F-4D19-8628-427836735343Q36642500-658C2EC4-95BA-4B9C-A2D3-1A49C0D2DBA0Q36782379-B0B07F6F-E8C2-47B0-A658-631891829374Q37550644-8F1037C3-9035-43EE-982D-27646BDA6ABFQ38950894-385F9345-99C7-4EB4-80A1-E933CE73885DQ40564497-81FF5700-3BD4-49F1-829B-627AD7E04C6FQ43202346-971A479B-38D7-46C7-9DD2-D3D35E6AE35AQ44475261-DFF7F76F-4E34-4308-A61C-31B2534F974FQ45074916-BDDA5EC3-C0B8-4AF8-82D5-AAF4D2D6AEF8Q53279967-F6ACEBA0-0294-4630-AB70-2424A057DABBQ55437517-4B435045-19ED-4E14-85F4-BBBDCAEF2E0C
P2860
Altered expression of transforming growth factor-beta ligands and receptors in primary and recurrent ovarian carcinoma.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Altered expression of transfor ...... d recurrent ovarian carcinoma.
@en
type
label
Altered expression of transfor ...... d recurrent ovarian carcinoma.
@en
prefLabel
Altered expression of transfor ...... d recurrent ovarian carcinoma.
@en
P2093
P2860
P1433
P1476
Altered expression of transfor ...... d recurrent ovarian carcinoma.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1097-0142(19990201)85:3<658::AID-CNCR16>3.0.CO;2-M
P407
P577
1999-02-01T00:00:00Z